Literature DB >> 11791096

Plasma concentrations of defensins and lactoferrin in children with severe sepsis.

Neal J Thomas1, Joseph A Carcillo, Lesley A Doughty, Howell Sasser, R Phillip Heine.   

Abstract

BACKGROUND: We hypothesized that systemic release of endogenous leukocyte-derived polypeptide antimicrobial defensins (polymorphonuclear leukocyte-specific) and lactoferrin (polymorphonuclear leukocyte and epithelial cell derived) occurs in nonneutropenic children with severe sepsis.
METHODS: We performed a prospective cross-sectional and longitudinal study in a university children's hospital pediatric intensive care unit. Ninety-two consecutive children meeting criteria for sepsis and 14 critically ill children without sepsis (controls) were enrolled, and plasma defensins and lactoferrin concentrations were measured on Days 1 and 3 of sepsis.
RESULTS: Nonneutropenic sepsis patients (n = 71) had increased defensins and lactoferrin plasma concentrations compared with critically ill control patients [defensins, 450 ng/ml vs. 150 ng/ml; lactoferrin, 332 ng/ml vs. 176 ng/ml (median values); P < 0.05] and neutropenic sepsis patients [n = 21; defensins, 450 ng/ml vs. 50 ng/ml; lactoferrin, 332 ng/ml vs. 20 ng/ml (median values); P < 0.05]. Neutropenic sepsis patients had similar plasma defensin concentrations and a decrease in plasma lactoferrin concentrations compared with control patients (P < 0.05). Defensins and lactoferrin plasma concentrations correlated to total white blood cell and absolute neutrophil count (P < 0.05). There was no association between plasma defensin concentration and organ failure or outcome; however, increased plasma lactoferrin concentrations were observed with the development of organ failure (P < 0.05).
CONCLUSION: These data suggest that increased circulating defensins and lactoferrin release are dependent in part on neutrophil count and might play a role in host defense in children with severe sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791096     DOI: 10.1097/00006454-200201000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

Review 1.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

2.  Dysregulation of human beta-defensin-3 expression in the peripheral blood of patients with sepsis.

Authors:  Noura Al Mansour; Ghada Al-Kafaji; Ali Al Mahmeed; Khalid M Bindayna
Journal:  SAGE Open Med       Date:  2021-08-23

3.  Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.

Authors:  Fu-Chen Huang; Yi-Ting Lu; Yu-Hsuan Liao
Journal:  Innate Immun       Date:  2020-09-28       Impact factor: 2.680

Review 4.  The Understanding and Management of Organism Toxicity in Septic Shock.

Authors:  Kelly Roveran Genga; Tadanaga Shimada; John H Boyd; Keith R Walley; James A Russell
Journal:  J Innate Immun       Date:  2018-05-15       Impact factor: 7.349

5.  High fidelity processing and activation of the human α-defensin HNP1 precursor by neutrophil elastase and proteinase 3.

Authors:  Prasad Tongaonkar; Amir E Golji; Patti Tran; André J Ouellette; Michael E Selsted
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

Review 6.  Antimicrobial peptides and their potential application in inflammation and sepsis.

Authors:  Tobias Schuerholz; Klaus Brandenburg; Gernot Marx
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

7.  The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients.

Authors:  Atabak Najafi; Mojtaba Mojtahedzadeh; Keyvan Haji Ahmadi; Mohammad Abdollahi; Maryam Mousavi; Legese Chelkeba; Farhad Najmeddin; Arezoo Ahmadi
Journal:  Daru       Date:  2014-07-15       Impact factor: 3.117

Review 8.  Endogenous antimicrobial factors in the treatment of infectious diseases.

Authors:  Paulina Żelechowska; Justyna Agier; Ewa Brzezińska-Błaszczyk
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

Review 9.  Antimicrobial Peptides in Human Sepsis.

Authors:  Lukas Martin; Anne van Meegern; Sabine Doemming; Tobias Schuerholz
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

10.  Modulation of Human Neutrophil Peptides on P. aeruginosa Killing, Epithelial Cell Inflammation and Mesenchymal Stromal Cell Secretome Profiles.

Authors:  Qingqing Dai; Yasumasa Morita; Yongbo Huang; Patricia C Liaw; Jianfeng Wu; Julie Khang; Diana Islam; Kaijiang Yu; Yimin Li; Haibo Zhang
Journal:  J Inflamm Res       Date:  2019-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.